Antonio Y. Hardan
Stanford University School of Medicine-Psychiatry and Behavioral Sciences - Child and Adolescent Psychiatry and Child Development · Stanford University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Antonio Y. Hardan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:04 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07635862 · Clinical Trial Evaluating the Effects of Ganaxolone in Children With AutismStanford University · not yet recruiting · Autism in Children, Autistic Disorder in Children and Adolescents, Autism Spectrum Disorder · principal investigator
- Ph2NCT05546554 · Trial of Suvorexant for Sleep in Children With AutismStanford University · recruiting · Autism, Autism Spectrum Disorder · principal investigator
- Ph2NCT05540574 · Trial of Zolpidem for Sleep in Children With AutismStanford University · recruiting · Autism, Autism Spectrum Disorder · principal investigator
- Ph2NCT05501678 · Trial of Diphenhydramine for Sleep in Children With AutismStanford University · recruiting · Autism, Autism Spectrum Disorder · principal investigator
- N/ANCT04899544 · Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in AutismStanford University · recruiting · Autism, Autism Spectrum Disorder, ASD · principal investigator
- N/ANCT04532424 · Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASDStanford University · recruiting · Autism Spectrum Disorder, Autism, Asperger Syndrome · principal investigator
- N/ANCT03778827 · A Center Based Study of Pivotal Response Treatment for Preschoolers With AutismStanford University · completed · Autism Spectrum Disorder, Autism · principal investigator
- Ph2/Ph3NCT03204786 · Intranasal Vasopressin Treatment in Children With AutismStanford University · completed · Autism, Autism Spectrum Disorder, ASD · principal investigator
- N/ANCT03131635 · Effectiveness of a Developmental Reciprocity Treatment Program in AutismStanford University · terminated · Autism Spectrum Disorder, Autism · principal investigator
- Ph2NCT02627508 · Pilot Trial of Pregnenolone in AutismStanford University · completed · Autism Spectrum Disorder, Autism · principal investigator
- N/ANCT01988623 · Pivotal Response Treatment for Individuals With Intellectual DisabilitiesStanford University · completed · Intellectual Disabilities, Speech Delay, Language Disorder · principal investigator
- Ph2NCT01962870 · The Role of Vasopressin in the Social Deficits of AutismStanford University · completed · Autism Spectrum Disorders
- N/ANCT01882153 · Evaluating Parent Delivered Interventions for Children With AutismStanford University · completed · Autistic Disorder, Developmental Disabilities
- Ph2NCT01624194 · Intranasal Oxytocin Treatment for Social Deficits in Children With AutismStanford University · completed · Autism
- N/ANCT01400269 · An Evaluation of a Developmentally-Based Parent Training Program for Children With AutismStanford University · completed · Autistic Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- A Multimodal Assessment Protocol for Characterizing Restricted and Repetitive Behaviors in AutismR01MH138412 · NIMH · STANFORD UNIVERSITY · fiscal years 2026 · $767,029 awarded in 2026Same name and institution; not confirmed by an ID
- A Randomized Controlled Double-Blind Trial of Everolimus for ImprovingSocial Abilities in PTEN Germline MutationsR01FD008531 · FDA · STANFORD UNIVERSITY · fiscal years 2026 · $647,968 awarded in 2026Same name and institution; not confirmed by an ID
- Project 2: Pharmacological Probing of Sleep Physiology in AutismP50HD109861 · NICHD · STANFORD UNIVERSITY · fiscal years 2022 to 2026 · $382,710 awarded in 2026Grant number is on one of their registry trials
- Toward better characterization and clinical trial readiness for targeting neuropsychiatric manifestations in PTEN pathogenic variantsU54NS092090 · NINDS · BOSTON CHILDREN'S HOSPITAL · fiscal years 2025 to 2026 · $326,308 awarded in 2026Same name and institution; not confirmed by an ID
- Developing a Quantitative Assessment Tool for Characterizing Social DomainsRF1MH129833 · NIMH · STANFORD UNIVERSITY · fiscal years 2025 · $1,425,865 awarded in 2025Same name and institution; not confirmed by an ID
- Developing a Quantitative Assessment Tool for Characterizing Social DomainsR01MH129833 · NIMH · STANFORD UNIVERSITY · fiscal years 2022 to 2024 · $743,927 awarded in 2024Same name and institution; not confirmed by an ID
- A Big Data Approach Toward the Development of a New Quantitative Measure of Restricted and Repetitive BehaviorsR21MH121876 · NIMH · STANFORD UNIVERSITY · fiscal years 2020 to 2021 · $197,125 awarded in 2021Same name and institution; not confirmed by an ID
- Intranasal vasopressin treatment in children with autismR01HD091972 · NICHD · STANFORD UNIVERSITY · fiscal years 2017 to 2021 · $581,063 awarded in 2021Grant number is on one of their registry trials
- Neuroimaging Predictors of Pivotal Response Treatment in Young Childrenwith AutismR21DC016089 · NIDCD · STANFORD UNIVERSITY · fiscal years 2018 to 2019 · $196,250 awarded in 2019Same name and institution; not confirmed by an ID
- Identification of RDoC Social Communication Sub-Constructs Using Existing DatasetsR03MH111846 · NIMH · STANFORD UNIVERSITY · fiscal years 2017 to 2018 · $78,500 awarded in 2018Same name and institution; not confirmed by an ID
- 2/2-Early Intervention for Youth at Risk for Bipolar DisorderR01MH093666 · NIMH · STANFORD UNIVERSITY · fiscal years 2016 · $271,215 awarded in 2016Same name and institution; not confirmed by an ID
- Quantitative Measurements of Cortical Excitability in Neurodevelopmental DisorderR21MH104774 · NIMH · STANFORD UNIVERSITY · fiscal years 2015 to 2016 · $197,500 awarded in 2016Same name and institution; not confirmed by an ID
- Pivotal Response Treatment Package for Young Children with AutismR21DC013689 · NIDCD · STANFORD UNIVERSITY · fiscal years 2014 to 2015 · $198,618 awarded in 2015Same name and institution; not confirmed by an ID
- The role of vasopressin in the social deficits of autismR21MH100387 · NIMH · STANFORD UNIVERSITY · fiscal years 2013 to 2014 · $196,250 awarded in 2014Grant number is on one of their registry trials
- A neuroimaging study of twin pairs with autismR01MH083972 · NIMH · STANFORD UNIVERSITY · fiscal years 2009 to 2013 · $599,326 awarded in 2013Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:04 UTC. The ranking covers the 200 most relevant of 23 PubMed records, and a shared surname and initials can bring in a namesake. All 23 on PubMed
- Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.Proc Natl Acad Sci U S A · 2017269 citationsRCR 12.1
- A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.Biol Psychiatry · 2012200 citationsRCR 6.7
- A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.Sci Transl Med · 2019138 citationsRCR 7.3
- A randomized controlled trial of Pivotal Response Treatment Group for parents of children with autism.J Child Psychol Psychiatry · 2015121 citationsRCR 6.4
- Precision microbial intervention improves social behavior but not autism severity: A pilot double-blind randomized placebo-controlled trial.Cell Host Microbe · 202481 citationsRCR 14.0
- Guanfacine in children with autism and/or intellectual disabilities.J Dev Behav Pediatr · 200877 citationsRCR 2.6
- Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.J Child Adolesc Psychopharmacol · 201771 citationsRCR 3.2
- A Pivotal Response Treatment Package for Children With Autism Spectrum Disorder: An RCT.Pediatrics · 201970 citationsRCR 5.4
- 45 citationsRCR 1.2
- 40 citationsRCR 2.0